Fiore JM - Search Results

1

Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.

Dosik AD, Coleman M, Kostakoglu L, Furman RR, Fiore JM, Muss D, Niesvizky R, Shore T, Schuster MW, Stewart P, Vallabhajosula S, Goldsmith SJ, Leonard JP. Dosik AD, et al. Among authors: fiore jm. Cancer. 2006 Feb 1;106(3):616-22. doi: 10.1002/cncr.21606. Cancer. 2006. PMID: 16362977 Free article.

2

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, Schuster MW, Niesvizky R, Muss D, Fiore J, Kroll S, Tidmarsh G, Vallabhajosula S, Goldsmith SJ. Leonard JP, et al. J Clin Oncol. 2005 Aug 20;23(24):5696-704. doi: 10.1200/JCO.2005.14.803. J Clin Oncol. 2005. PMID: 16110029 Clinical Trial.

3

Epratuzumab: targeting B-cell malignancies through CD22.

Coleman M, Goldenberg DM, Siegel AB, Ketas JC, Ashe M, Fiore JM, Leonard JP. Coleman M, et al. Among authors: fiore jm. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3991S-4S. Clin Cancer Res. 2003. PMID: 14506198 Review.

4

Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, Niesvizky R, Shore T, Chadburn A, Horne H, Kovacs J, Ding CL, Wegener WA, Horak ID, Goldenberg DM. Leonard JP, et al. Among authors: fiore jm. J Clin Oncol. 2005 Aug 1;23(22):5044-51. doi: 10.1200/JCO.2005.13.821. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955901 Clinical Trial.

5

Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma.

Matei D, Hagag N, Madajewicz S, Chowhan N, Hentschel P, Avvento L, Burns P, Fiore J, Lipera W, Zarrabi H. Matei D, et al. Cancer. 1995 Oct 15;76(8):1330-5. doi: 10.1002/1097-0142(19951015)76:8<1330::aid-cncr2820760806>3.0.co;2-2. Cancer. 1995. PMID: 8620405 Clinical Trial.

6

Patient-specific vaccine therapy for non-Hodgkin lymphoma.

Hohenstein M, King SE, Fiore JM, O'Brien T, Blumel S. Hohenstein M, et al. Among authors: fiore jm. Clin J Oncol Nurs. 2005 Feb;9(1):85-90. doi: 10.1188/05.CJON.85-90. Clin J Oncol Nurs. 2005. PMID: 15751502 Review.

7

Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies.

Madajewicz S, Hentschel P, Burns P, Caruso R, Fiore J, Fried M, Malhotra H, Ostrow S, Sugarman S, Viola M. Madajewicz S, et al. J Clin Oncol. 2000 Oct 15;18(20):3553-7. doi: 10.1200/JCO.2000.18.20.3553. J Clin Oncol. 2000. PMID: 11032598 Clinical Trial.

8

Normal G2 chromosomal radiosensitivity and cell survival in the cancer family syndrome.

Bender MA, Viola MV, Fiore J, Thompson MH, Leonard RC. Bender MA, et al. Cancer Res. 1988 May 1;48(9):2579-84. Cancer Res. 1988. PMID: 3356018

9

Protein A immunoadsorption in the treatment of malignant disease.

Messerschmidt GL, Henry DH, Snyder HW Jr, Bertram J, Mittelman A, Ainsworth S, Fiore J, Viola MV, Louie J, Ambinder E, et al. Messerschmidt GL, et al. J Clin Oncol. 1988 Feb;6(2):203-12. doi: 10.1200/JCO.1988.6.2.203. J Clin Oncol. 1988. PMID: 3276821 Clinical Trial.

10

Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.

Kambhu SA, Kelsen DP, Fiore J, Niedzwiecki D, Chapman D, Vinciguerra V, Rosenbluth R. Kambhu SA, et al. Am J Clin Oncol. 1990 Feb;13(1):55-60. doi: 10.1097/00000421-199002000-00015. Am J Clin Oncol. 1990. PMID: 2106257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters